Thompson CB - Search Results

1

Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.

Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB, Fesik SW. Sattler M, et al. Among authors: thompson cb. Science. 1997 Feb 14;275(5302):983-6. doi: 10.1126/science.275.5302.983. Science. 1997. PMID: 9020082

2

Solution structure of the ets domain of Fli-1 when bound to DNA.

Liang H, Mao X, Olejniczak ET, Nettesheim DG, Yu L, Meadows RP, Thompson CB, Fesik SW. Liang H, et al. Among authors: thompson cb. Nat Struct Biol. 1994 Dec;1(12):871-5. doi: 10.1038/nsb1294-871. Nat Struct Biol. 1994. PMID: 7773776

3

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.

Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng SL, Fesik SW. Muchmore SW, et al. Among authors: thompson cb. Nature. 1996 May 23;381(6580):335-41. doi: 10.1038/381335a0. Nature. 1996. PMID: 8692274

4

Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.

Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB. Chang BS, et al. Among authors: thompson cb. EMBO J. 1997 Mar 3;16(5):968-77. doi: 10.1093/emboj/16.5.968. EMBO J. 1997. PMID: 9118958 Free PMC article.

5

Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.

Minn AJ, Kettlun CS, Liang H, Kelekar A, Vander Heiden MG, Chang BS, Fesik SW, Fill M, Thompson CB. Minn AJ, et al. Among authors: thompson cb. EMBO J. 1999 Feb 1;18(3):632-43. doi: 10.1093/emboj/18.3.632. EMBO J. 1999. PMID: 9927423 Free PMC article.

6

Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, Mack J, Swift K, Matayoshi ED, Zhang H, Thompson CB, Fesik SW. Petros AM, et al. Among authors: thompson cb. Protein Sci. 2000 Dec;9(12):2528-34. doi: 10.1110/ps.9.12.2528. Protein Sci. 2000. PMID: 11206074 Free PMC article.

7

Expression of bcl-xL can confer a multidrug resistance phenotype.

Minn AJ, Rudin CM, Boise LH, Thompson CB. Minn AJ, et al. Among authors: thompson cb. Blood. 1995 Sep 1;86(5):1903-10. Blood. 1995. PMID: 7655019 Free article.

8

The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein.

Liang H, Olejniczak ET, Mao X, Nettesheim DG, Yu L, Thompson CB, Fesik SW. Liang H, et al. Among authors: thompson cb. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11655-9. doi: 10.1073/pnas.91.24.11655. Proc Natl Acad Sci U S A. 1994. PMID: 7972119 Free PMC article.

9

Bcl-x(L) forms an ion channel in synthetic lipid membranes.

Minn AJ, Vélez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill M, Thompson CB. Minn AJ, et al. Among authors: thompson cb. Nature. 1997 Jan 23;385(6614):353-7. doi: 10.1038/385353a0. Nature. 1997. PMID: 9002522

10

Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.

Kelekar A, Chang BS, Harlan JE, Fesik SW, Thompson CB. Kelekar A, et al. Among authors: thompson cb. Mol Cell Biol. 1997 Dec;17(12):7040-6. doi: 10.1128/MCB.17.12.7040. Mol Cell Biol. 1997. PMID: 9372935 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

723 results

Search Page

Filters